← back to search

Yibin Feng

Chinese University of Hong Kong · CN
Area of research
Pharmacology · Epidemiology
Research interest
Research interests include Berberine and alkaloids research, Pharmacological Effects of Natural Compounds, Liver Disease Diagnosis and Treatment, and Drug-Induced Hepatotoxicity and Protection.
h-index
68
citations
25,182
works
331
NIH funding
primary concept
Medicine
email

Recent publications

Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives
Pharmacological Research 2025cited by 12position: lastdoi
Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development
Molecular Cancer 2025cited by 8position: lastdoi
Chemotherapy cardiotoxicity research in cancer patients: a bibliometric and visual analysis (1994–2024)
Frontiers in Oncology 2025cited by 6position: lastdoi
Mulberry twig alkaloids for type 2 diabetes mellitus: a systematic review and meta-analysis
Frontiers in Pharmacology 2025cited by 2position: lastdoi
The role of Chinese medicines in targeting non-coding RNAs to overcome cancer drug resistance: Mechanisms and clinical translation challenges
Pharmacological Research 2025cited by 1position: lastdoi
A bibliometric analysis of targeted therapy cardiotoxicity research in cancer patients (2004–2024)
Frontiers in Medicine 2025cited by 1position: lastdoi
Correction: Bridging the tumor microenvironment: the pivotal role of cancer-associated fibroblasts in tumor cachexia development
Molecular Cancer 2025cited by 0position: lastdoi
Herbal medicines for radiation vaginitis: A systematic review and meta-analysis
Phytomedicine 2025cited by 0position: lastdoi
Association Between Dietary Vitamin K Intake With Cancer Cachexia and Mortality: <scp>NHANES</scp> 1999–2018
Food Science & Nutrition 2025cited by 0position: lastdoi
Effects and mechanisms of anti-diabetic dietary natural products: an updated review
Food & Function 2024cited by 31position: middledoi
Exploring the gut microbiome’s role in colorectal cancer: diagnostic and prognostic implications
Frontiers in Immunology 2024cited by 25position: lastdoi
The Role of Non-Coding RNAs in Regulating Cachexia Muscle Atrophy
Cells 2024cited by 5position: lastdoi
Unravelling the role of natural and synthetic products as DNA topoisomerase inhibitors in hepatocellular carcinoma
Bioorganic Chemistry 2024cited by 4position: lastdoi
BBOX1, LACC1, MMP7 and SSTR1 as common predictors in obesity and non-alcoholic fatty liver disease
Genes & Diseases 2024cited by 3position: middledoi
Bioactive compounds and health benefits of pomegranate: An updated narrative review
Food Bioscience 2023cited by 44position: middledoi
Characterization of cuproptosis in gastric cancer and relationship with clinical and drug reactions
Frontiers in Cell and Developmental Biology 2023cited by 9position: lastdoi
HAMP as a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
Biomolecules 2023cited by 6position: lastdoi
Efficacy and safety of herbal medicines intervention for cachexia associated with cancer: A systematic review and meta‐analysis
Phytotherapy Research 2023cited by 6position: lastdoi
Elderberry (<i>Sambucus nigra</i> L.): Bioactive Compounds, Health Functions, and Applications
Journal of Agricultural and Food Chemistry 2022cited by 84position: middledoi
GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
Frontiers in Immunology 2022cited by 75position: lastdoi
Using omics approaches to dissect the therapeutic effects of Chinese herbal medicines on gastrointestinal cancers
Frontiers in Pharmacology 2022cited by 6position: middledoi
HAMP Is a Potential Diagnostic, PD-(L)1 Immunotherapy Sensitivity and Prognostic Biomarker in Hepatocellular Carcinoma
SSRN Electronic Journal 2022cited by 0position: lastdoi
Efficacy and Safety of Herbal Medicines Intervention for Cachexia Associated with Cancer: A Systematic Review and Meta-Analysis
SSRN Electronic Journal 2022cited by 0position: lastdoi
Green Tea and Epigallocatechin Gallate (EGCG) for the Management of Nonalcoholic Fatty Liver Diseases (NAFLD): Insights into the Role of Oxidative Stress and Antioxidant Mechanism
Antioxidants 2021cited by 126position: lastdoi
Effects and mechanisms of tea on obesity
Critical Reviews in Food Science and Nutrition 2021cited by 69position: middledoi
Health Functions and Related Molecular Mechanisms of Tea Components: An Update Review
International Journal of Molecular Sciences 2019cited by 397position: middledoi
Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network
Frontiers in Pharmacology 2019cited by 62position: lastdoi
Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells
Frontiers in Pharmacology 2019cited by 51position: middledoi
The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases
Oxidative Medicine and Cellular Longevity 2018cited by 193position: lastdoi
microRNA-23a in Human Cancer: Its Roles, Mechanisms and Therapeutic Relevance
Cancers 2018cited by 100position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ning Wang · Sheffield Hallam University17 papers (2016–2025)Cheng Zhang · Chinese Academy of Social Sciences12 papers (2018–2025)Guo-Ming Chen · Guangzhou University of Chinese Medicine8 papers (2022–2025)Guoyi Tang · Chinese University of Hong Kong6 papers (2019–2025)Hua‐Bin Li · Liaocheng University6 papers (2019–2024)Dongqiang Luo · Guangzhou University of Chinese Medicine5 papers (2022–2024)Ming Hong · Guangzhou University of Chinese Medicine5 papers (2016–2022)Danyun Li · Guangzhou University of Chinese Medicine5 papers (2022–2024)Ren‐You Gan · Hong Kong Polytechnic University5 papers (2019–2024)Bonan Chen · Guangzhou University of Chinese Medicine5 papers (2023–2025)Zilan Zhong · Guangzhou University of Chinese Medicine4 papers (2024–2025)Rui Qin · Guangzhou University of Chinese Medicine4 papers (2025–2025)Guoming Chen · China University of Petroleum, East China4 papers (2024–2025)Qing Ren · Hubei University of Medicine4 papers (2022–2024)Sha Li · Guizhou University4 papers (2016–2019) · 4 papers (2025–2025)Hor‐Yue Tan · Hong Kong Baptist University3 papers (2018–2019)Peizhen Huang · Guangzhou University of Chinese Medicine3 papers (2022–2024)Hui Liao · Guangzhou University of Chinese Medicine3 papers (2022–2023)Ao Shang · University of Hong Kong2 papers (2021–2023)